Razadyne and Pain - a phase IV clinical study of FDA data

Summary:

Pain is reported as a side effect among people who take Razadyne (galantamine hydrobromide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Aspirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Pain when taking Razadyne. It is created by eHealthMe based on reports of 596 people who have side effects when taking Razadyne from the FDA, and is updated regularly.

What is Razadyne?

Razadyne has active ingredients of galantamine hydrobromide. It is often used in insomnia. eHealthMe is studying from 691 Razadyne users. Check the latest studies of Razadyne.

What is Pain?

Pain is found to be associated with 3,807 drugs and 5,872 conditions by eHealthMe. Check the latest studies of Pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

596 people reported to have side effects when taking Razadyne.
Among them, 19 people (3.19%) have Pain.

Among these 19 people:

How long have people been on Razadyne when they have Pain? *

What is the gender of people who have Pain when taking Razadyne? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Pain when taking Razadyne? *

What are other drugs people take besides Razadyne? *

What are other side effects people have besides Pain? *

Stress And Anxiety: 13 people, 68.42%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 13 people, 68.42%
Fatigue (feeling of tiredness): 12 people, 63.16%
Muscle Aches (muscle pain): 10 people, 52.63%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 52.63%
Cataract (clouding of the lens inside the eye): 10 people, 52.63%
Urinary Tract Infection: 8 people, 42.11%
Muscle Spasms (muscle contraction): 8 people, 42.11%
Cerebral Atrophy (decrement in size of brain): 8 people, 42.11%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 8 people, 42.11%

What are the existing conditions these people have? *

Asthma: 2 people, 10.53%
Breakthrough Pain: 2 people, 10.53%
Pain In Extremity: 2 people, 10.53%
Joint Pain: 2 people, 10.53%
Sleep Disorder: 2 people, 10.53%
High Blood Pressure: 2 people, 10.53%
High Blood Cholesterol: 1 person, 5.26%
Cardiac Disorder: 1 person, 5.26%
Cardiac Failure Congestive: 1 person, 5.26%
Craniocerebral Injury (injury to cranium and brain): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Razadyne and have Pain?

- Check whether Pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Razadyne:

Razadyne (691 reports)

Pain treatments and more:

Pain (1,140,596 reports)

Browse all side effects of Razadyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain:

Pain (3,807 drugs)

Browse all the conditions that are associated with Pain:

Pain (5,872 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide (the active ingredients of Razadyne) and Razadyne (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.